Highlights
- Medicare negotiations may lower drug costs by $1.5 billion annually for enrollees.
- Beneficiaries should reevaluate their plans during the October–December 2025 enrollment period.
Summary of Medicare Changes for 2026
Starting January 2026, Medicare will introduce key changes to coverage, costs, provider payments, and services based on CMS’s annual rulemaking. Notable updates include Medicare-negotiated prices for ten high-cost drugs, reducing beneficiary spending by about $1.5 billion annually, an expanded $35 annual insulin cost cap, and coverage of certain weight-loss drugs with low copays. The Part D out-of-pocket cap will rise slightly from $2,000 to $2,100. Traditional Medicare will pilot prior authorization for select procedures in six states to curb unnecessary care. Medicare Advantage plans will face restrictions on supplemental benefits, while telehealth policies will expand permanently. Payment reforms include updated practice expense valuations and new risk-based models, with some specialties seeing modest payment cuts. These changes aim to enhance affordability and quality but raise concerns about administrative burdens and access. Beneficiaries should review plans carefully during the October–December 2025 enrollment period.
Key Policy Updates and Impacts
The 2026 Physician Fee Schedule introduces expanded care coordination services, revised geographic payment indices, and broader colorectal cancer screening options. Medicare will cover advanced primary care management with 24/7 access and broaden CT colonography screening. Geographic practice cost indices will adjust after January 30, 2026, unless Congress acts.
Prescription drug changes include Medicare-negotiated lower prices on ten expensive drugs covering arthritis, cancer, diabetes, and more, alongside a modest increase in the Part D out-of-pocket cap. Insulin cost-sharing will cap annually at $35, with beneficiaries paying the lesser of 25% coinsurance of fair or negotiated prices. Medicare will also cover select weight-loss medications with low beneficiary copays.
Prior authorization will be required for 17 procedures in six pilot states under Traditional Medicare, with AI tools introduced to streamline approvals. Medicare Advantage plans will see reduced supplemental benefit options, and telehealth policies will permanently remove limits on virtual visits for hospital and skilled nursing patients, allowing virtual supervision and maintaining providers’ primary practice location for enrollment.
New payment models will include a two-sided risk framework adjusting Part B reimbursements by ±9%, focusing on quality, cost, and care coordination. Efficiency adjustments will reduce payments by about 1% for some specialties. Providers should anticipate operational impacts and review contracts accordingly.
Effects on Beneficiaries and Providers
Beneficiaries will face income-related Part B premium adjustments affecting about 8% of enrollees. Insulin cost-sharing improvements and capped drug costs aim to enhance affordability. However, fewer standalone Part D plans and reduced supplemental benefits narrow choices. Open Enrollment runs October 15 to December 7, 2025, with coverage changes effective January 1, 2026. Medigap Plan C and high-deductible Plan F remain unavailable for new enrollees.
Providers will experience changes in payment reflecting shifts toward hospital-based care, with increased valuation for office-based indirect expenses and efficiency adjustments that reduce payments for certain specialties. Telehealth expansions offer greater flexibility, while prior authorization in pilot states introduces new administrative requirements. Providers should prepare for these operational changes and policy impacts.
Enrollment and Planning
Medicare Open Enrollment for 2026 is from October 15 to December 7, 2025. Beneficiaries can enroll, switch, or modify plans, with fewer Medicare Advantage options but expected lower average premiums. CMS will publish provider directory data by October 1, 2025, to assist plan selection. Both beneficiaries and providers should proactively review changes and seek guidance, such as from State Health Insurance Assistance Programs (SHIP).
Policy Goals and Challenges
CMS aims to improve Medicare affordability, access, and quality through drug cost reductions, expanded preventive services, and enhanced care coordination. Challenges include ongoing healthcare cost growth, administrative burdens from prior authorization, and regulatory complexities. Efforts to safeguard against waste and fraud continue alongside expansions in service delivery and consumer protections.
Comparison with Prior Years
The 2026 updates build on prior reforms by emphasizing affordability and preventive care, including capped drug costs and broader screening access. However, supplemental benefits for chronically ill Medicare Advantage enrollees are being curtailed due to high costs. Payment reforms and procedural codifications continue to evolve, maintaining program stability while adapting to changing healthcare delivery and policy priorities.